Portal de investigación
- Inicio
- Publicaciones
- A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial-A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin.
A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial-A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Perez-Fidalgo, JA
- Bohn, U
- Calvo, E
- Garcia, YG
- Guerra, EM
- Iglesias, M
- Manso, L
- Gonzalez-Martin, A
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0732-183X, 1527-7755
- Tipo:
- Meeting Abstract
- Páginas:
- -
- Factor de Impacto:
- 11,754 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF CLINICAL ONCOLOGY LIPPINCOTT WILLIAMS & WILKINS
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Perez,JA,Bohn,U,Calvo,E,Garcia,YG,Guerra,EM,Iglesias,M,Manso,L et al. A multicentric single-arm phase II clinical trial to evaluate safety and efficacy of the combination of olaparib and PLD for platinum resistant ovarian primary peritoneal carcinoma and fallopian tube cancer patients: The GEICO-1601 ROLANDO trial-A trial in resistant ovarian cancer with olaparib and pegylated liposomal doxorubicin. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2018.